H Hamada Selected Research

H Hamada Research Topics

Disease

41	Neoplasms (Cancer) 01/2016 - 01/2000
19	Glioma (Gliomas) 08/2012 - 01/2000
8	Infections 07/2004 - 03/2000
6	Asthma (Bronchial Asthma) 06/2023 - 02/2000
6	Carcinoma (Carcinomatosis) 09/2012 - 02/2000
5	Rheumatoid Arthritis 01/2022 - 03/2000
5	Colonic Neoplasms (Colon Cancer) 03/2003 - 02/2000
4	Ischemia 09/2007 - 01/2000
4	Inflammation (Inflammations) 05/2007 - 02/2000
4	Brain Neoplasms (Brain Tumor) 11/2001 - 01/2000
4	Adenoma (Adenomas) 08/2001 - 04/2000
4	Colorectal Neoplasms (Colorectal Cancer) 07/2001 - 03/2000
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 02/2013 - 05/2001
3	Malignant Hyperthermia 03/2012 - 05/2009
3	Hydrocephalus (Hydrocephaly) 04/2009 - 12/2000
3	Brain Ischemia (Cerebral Ischemia) 09/2007 - 01/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2006 - 01/2000
3	Lung Neoplasms (Lung Cancer) 10/2001 - 01/2000
3	Renal Cell Carcinoma (Grawitz Tumor) 03/2000 - 01/2000
2	Infarction (Infarctions) 09/2007 - 01/2005
2	Respiratory Hypersensitivity 05/2007 - 10/2001
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2006 - 01/2005
2	Cysts 08/2005 - 12/2000
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2003 - 05/2001
2	Pre-Eclampsia (Preeclampsia) 12/2001 - 01/2000
2	Esophageal Neoplasms (Esophageal Cancer) 07/2001 - 01/2001
2	Hepatocellular Carcinoma (Hepatoma) 03/2001 - 05/2000
2	Breast Neoplasms (Breast Cancer) 03/2001 - 05/2000
2	Astrocytoma (Pilocytic Astrocytoma) 02/2001 - 10/2000
2	Gastritis 06/2000 - 03/2000
2	Coinfection 05/2000 - 01/2000
1	Anaphylaxis (Anaphylactic Shock) 06/2023
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Necrosis 01/2020
1	Developmental Dysplasia of the Hip 07/2017
1	Hip Osteoarthritis (Coxarthrosis) 07/2017
1	Human Influenza (Influenza) 03/2015

Drug/Important Bio-Agent (IBA)

9	Cytosine DeaminaseIBA 08/2012 - 01/2000
7	Flucytosine (Ancobon)FDA Link 08/2012 - 01/2000
6	CytokinesIBA 05/2007 - 01/2000
6	Proteins (Proteins, Gene)FDA Link 03/2006 - 01/2000
6	Interleukin-12 (IL 12)IBA 10/2001 - 01/2000
6	Fas Ligand Protein (Fas Ligand)IBA 09/2001 - 03/2000
6	Fluorouracil (Carac)FDA LinkGeneric 07/2001 - 03/2000
5	AntigensIBA 01/2021 - 03/2000
5	Caspase 8 (Caspase-8)IBA 10/2001 - 05/2000
5	uracil phosphoribosyltransferaseIBA 01/2001 - 01/2000
4	Thymidine KinaseIBA 02/2009 - 01/2000
4	Messenger RNA (mRNA)IBA 04/2005 - 02/2000
4	Interleukin-2 (IL2)IBA 07/2004 - 02/2000
4	VaccinesIBA 05/2002 - 03/2000
4	Caspase 9IBA 02/2002 - 04/2001
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2001 - 01/2000
3	Ganciclovir (Cytovene)FDA LinkGeneric 02/2009 - 01/2000
3	Interferon-gamma (Interferon, gamma)IBA 02/2008 - 02/2000
3	AcidsIBA 06/2005 - 03/2000
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2003 - 06/2000
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2001 - 02/2001
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2001 - 01/2000
3	NF-kappa B (NF-kB)IBA 01/2001 - 01/2000
3	ProdrugsIBA 07/2000 - 01/2000
3	Myelin Basic ProteinIBA 05/2000 - 02/2000
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2020
2	Abatacept (Orencia)FDA Link 01/2021 - 01/2020
2	Caspase 3 (Caspase-3)IBA 02/2013 - 05/2000
2	UbiquitinIBA 09/2012 - 01/2000
2	Therapeutic UsesIBA 08/2012 - 07/2001
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 03/2011 - 05/2009
2	Propofol (Diprivan)FDA LinkGeneric 05/2009 - 07/2001
2	SelectinsIBA 04/2008 - 11/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2007 - 06/2000
2	Complementary DNA (cDNA)IBA 11/2005 - 10/2001
2	Indicators and Reagents (Reagents)IBA 11/2001 - 01/2000
2	Immunoglobulin E (IgE)IBA 10/2001 - 02/2000
2	EnzymesIBA 07/2000 - 03/2000
2	Cancer VaccinesIBA 03/2000 - 03/2000
1	dupilumabIBA 06/2023
1	Janus Kinase InhibitorsIBA 01/2022
1	Janus KinasesIBA 01/2022
1	AntibodiesIBA 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2020
1	Anti-Citrullinated Protein AntibodiesIBA 01/2020
1	Aspartic Acid (Aspartate)FDA Link 07/2017
1	Single-Chain AntibodiesIBA 01/2016
1	Antiviral Agents (Antivirals)IBA 03/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2013
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 09/2012
1	Matrix Metalloproteinases (MMPs)IBA 09/2012
1	Ligases (Synthetase)IBA 09/2012
1	Neuroprotective AgentsIBA 08/2012
1	Sevoflurane (Ultane)FDA LinkGeneric 03/2012
1	Anesthetics (Anesthetic Agents)IBA 03/2012

Therapy/Procedure

22	Therapeutics 09/2012 - 01/2000
4	Drug Therapy (Chemotherapy) 07/2004 - 05/2000
3	Radiotherapy 07/2001 - 05/2000
2	Ventriculoperitoneal Shunt 04/2009 - 12/2000
2	Intravenous Infusions 05/2006 - 06/2005
2	Immunotherapy 05/2002 - 04/2000
1	Aftercare (After-Treatment) 01/2021
1	Conservative Treatment 07/2017